Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Profile of TI-138067, a novel tubulin inhibitor in phase I testing

Sep. 1, 1998

ProScript team describes novel Ras endoprotease inhibitor at ACS meeting

Sep. 1, 1998

New anticancer agents discovered at American Cyanamid

Sep. 1, 1998

Prolifix and BioFocus to cooperate on cancer drug development

Sep. 1, 1998

Boehringer Mannheim reports new discovery in cancer research

Sep. 1, 1998

Northwest Biotherapeutics patents dendritic cell-based immunotherapy for prostate cancer

Sep. 1, 1998

Thalidomide analogue inhibits tumor metastasis in melanoma-bearing mice

Aug. 31, 1998

Pfizer describes use of protein tyrosine kinase inhibitors to treat hyperproliferative disorders

Aug. 31, 1998

Antineoplastic phenanthridinium compounds discovered at Nippon Kayaku

Aug. 31, 1998

Nordic Drugs to distribute Xechem's paclitaxel products in Scandinavia

Aug. 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.